Immune thrombocytopenic purpura after SARS-CoV-2 vaccine.
作者信息
Candelli Marcello, Rossi Elena, Valletta Federico, De Stefano Valerio, Franceschi Francesco
机构信息
Emergency Medicine Department, Fondazione Universitaria Policlinico A. Gemelli - IRCCS - Catholic University of Sacred Heart of Rome, Rome, Italy.
Diagnostic Imaging, Oncological Radiotherapy, and Hematology Department, Fondazione Universitaria Policlinico A. Gemelli - IRCCS - Catholic University of Sacred Heart of Rome, Rome, Italy.
出版信息
Br J Haematol. 2021 Aug;194(3):547-549. doi: 10.1111/bjh.17508. Epub 2021 May 2.
Abstract
摘要
相似文献
1
Immune thrombocytopenic purpura after SARS-CoV-2 vaccine.新型冠状病毒2型疫苗接种后免疫性血小板减少性紫癜
Br J Haematol. 2021 Aug;194(3):547-549. doi: 10.1111/bjh.17508. Epub 2021 May 2.
2
Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).接种新型冠状病毒疫苗（ChAdOx1 nCoV-19）后发生免疫性血小板减少性紫癜
Blood. 2021 Sep 16;138(11):996-999. doi: 10.1182/blood.2021012790.
3
Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine.一名22岁接种新冠疫苗后出现的免疫性血小板减少症。
Am J Hematol. 2021 May 1;96(5):E133-E134. doi: 10.1002/ajh.26106. Epub 2021 Feb 11.
4
Acute immune thrombocytopenia following SARS-CoV-2 vaccination in chronic ITP patients and a healthy individual.慢性免疫性血小板减少症患者及一名健康个体接种新型冠状病毒2疫苗后发生急性免疫性血小板减少症
Int J Hematol. 2022 Feb;115(2):293-295. doi: 10.1007/s12185-021-03235-2. Epub 2021 Oct 30.
5
Perspectives on vaccine induced thrombotic thrombocytopenia.疫苗诱导的血栓性血小板减少症的观点。
J Autoimmun. 2021 Jul;121:102663. doi: 10.1016/j.jaut.2021.102663. Epub 2021 May 18.
6
AZD1222 vaccine-related coagulopathy and thrombocytopenia without thrombosis in a young female.一名年轻女性出现与AZD1222疫苗相关的凝血障碍和血小板减少症，无血栓形成。
Br J Haematol. 2021 Aug;194(3):553-556. doi: 10.1111/bjh.17530. Epub 2021 May 25.
7
Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways.接种 SARS-CoV-2 疫苗后发生的凝血功能障碍可能源于 SARS-CoV-2 刺突蛋白和腺病毒载体触发的信号通路的综合作用。
Int J Mol Sci. 2021 Oct 6;22(19):10791. doi: 10.3390/ijms221910791.
8
Immune Thrombocytopenic Purpura (ITP) Triggered by COVID-19 Infection and Vaccination.由新冠病毒感染和疫苗接种引发的免疫性血小板减少性紫癜（ITP）
Isr Med Assoc J. 2021 Jun;23(6):378-380.
9
Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know.疫苗诱导的免疫性血栓性血小板减少症：我们已知和未知的。
Blood. 2021 Jul 29;138(4):293-298. doi: 10.1182/blood.2021012152. Epub 2021 Jun 1.
10
Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.免疫性血小板减少症患者接种抗SARS-CoV-2疫苗的安全性
Br J Haematol. 2021 Dec;195(5):703-705. doi: 10.1111/bjh.17813. Epub 2021 Aug 31.
引用本文的文献
1
ChAdOx1 nCoV-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome among Adults: A Systematic Review.ChAdOx1新型冠状病毒疫苗与成人血栓形成伴血小板减少综合征：一项系统评价
Adv Pharm Bull. 2023 Nov;13(4):723-735. doi: 10.34172/apb.2023.081. Epub 2023 Apr 29.
2
Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review.2019冠状病毒病疫苗诱导的皮肤并发症的管理：一项全面的文献综述。
J Family Community Med. 2023 Jul-Sep;30(3):161-170. doi: 10.4103/jfcm.jfcm_3_23. Epub 2023 Jul 24.
3
A case of APMPPE-like panuveitis presenting with extensive outer retinal layer impairment following COVID-19 vaccination.一例 COVID-19 疫苗接种后出现广泛的外层视网膜损伤的 APMPPE 样全葡萄膜炎。
BMC Ophthalmol. 2023 May 24;23(1):233. doi: 10.1186/s12886-023-02978-2.
4
An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations.关于 COVID-19 mRNA 疫苗的深入概述：优势、药理学、作用机制和前瞻性考虑。
Int Immunopharmacol. 2023 Apr;117:109934. doi: 10.1016/j.intimp.2023.109934. Epub 2023 Feb 27.
5
Editorial for "Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form".《无症状/轻症型 COVID-19 患者的 COVID-19 后综合征》社论
Pathogens. 2023 Jan 20;12(2):167. doi: 10.3390/pathogens12020167.
6
Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.COVID-19 疫苗接种相关免疫性血小板减少性紫癜：一项系统评价。
Eur J Haematol. 2023 Apr;110(4):335-353. doi: 10.1111/ejh.13917. Epub 2022 Dec 30.
7
A Systematic Review of Reported Cases of Immune Thrombocytopenia after COVID-19 Vaccination.新型冠状病毒肺炎疫苗接种后免疫性血小板减少症报告病例的系统评价
Vaccines (Basel). 2022 Sep 1;10(9):1444. doi: 10.3390/vaccines10091444.
8
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.接种 COVID-19 疫苗后的自身免疫和自身炎症性疾病。新病例报告和最新文献回顾。
J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24.
9
Case Report: Subacute thyroiditis after receiving inactivated SARS-CoV-2 vaccine (BBIBP-CorV).病例报告：接种新型冠状病毒灭活疫苗（BBIBP-CorV）后发生亚急性甲状腺炎。
Front Med (Lausanne). 2022 Jul 22;9:918721. doi: 10.3389/fmed.2022.918721. eCollection 2022.
10
Immune Thrombocytopenia in Previously Healthy Individuals Following SARS-CoV-2 Vaccination (COVID-19 Immunization): A Descriptive Research of 70 Instances With a Focus on Biomarkers, Predictive Outcomes, and Consequences.新型冠状病毒疫苗接种（COVID-19免疫）后既往健康个体出现的免疫性血小板减少症：70例病例的描述性研究，重点关注生物标志物、预测结果和后果
Cureus. 2022 Jul 1;14(7):e26480. doi: 10.7759/cureus.26480. eCollection 2022 Jul.
本文引用的文献
1
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.辉瑞和莫德纳新冠疫苗接种后出现的血小板减少症。
Am J Hematol. 2021 May 1;96(5):534-537. doi: 10.1002/ajh.26132. Epub 2021 Mar 9.
2
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.Ad26.COV2.S 新冠疫苗 1/2a 期临床试验的中期结果。
N Engl J Med. 2021 May 13;384(19):1824-1835. doi: 10.1056/NEJMoa2034201. Epub 2021 Jan 13.
3
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
4
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗（阿斯利康）对 SARS-CoV-2 的安全性和有效性：巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
5
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
6
Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance.腺病毒诱导的血小板减少症：血管性血友病因子和P选择素在介导血小板加速清除中的作用。
Blood. 2007 Apr 1;109(7):2832-9. doi: 10.1182/blood-2006-06-032524.
Zotero 插件